Mark A. Feitelson - Concepedia

Author

Mark A. Feitelson

Also Known As

M A Feitelson, M FEITELSON, M Feitelson, M. A. Feitelson, M.A. Feitelson, MARK A. FEITELSON, Mark A Feitelson, Mark A. Feitelson, Mark Alan Feitelson, Mark FEITELSON

237

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson University Fox Chase Cancer Center Temple University Sidney Kimmel Cancer Center Second Military Medical University

About

Mark A. Feitelson is an author at Thomas Jefferson University specializing in medicine, hepatitis, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	41	2.9K
2	Natural Sciences	4	4	81
3	Health Sciences	3	3	450
4	Biochemistry	2	2	48
5	Engineering	1	1	10

Mark A. Feitelson

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Xin Wei Wang, Kathleen Forrester, Heidi Yeh, Proceedings of the National Academy of Sciences Dna VirusImmunologyHepatitis BP53 FunctionsCancer-associated Virus	1994	662
Functional inactivation but not structural mutation of p53 causes liver cancer Hiroyuki Ueda, Stephen J. Ullrich, J. David Gangemi, Nature Genetics Tumor BiologyOncogenic AgentLiver PhysiologyCell DeathFunctional Inactivation	1995	370
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. Martin Höhne, Stephan Schaefer, Maria Seifer, The EMBO Journal HepatologyViral HepatitisMalignant TransformationHepatitis BHepatitis	1990	234
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Mark A. Feitelson, Lifeng Duan PubMed	1997	226
Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells Kyoungsub Song, Chang Han, Jinqiang Zhang, Hepatology	2013	131
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Wang Wl, William T. London, Mark A. Feitelson PubMed Primary Hepatocellular CarcinomaImmunologyHepatitis BPathologyCirrhosis	1991	125
Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly Guoyi Wu, Bo Liu, Yingjun Zhang, Antimicrobial Agents and Chemotherapy	2013	121
Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells? Alla Arzumanyan, Tiffany Friedman, Irene Oi‐Lin Ng, Cancer Research ImmunologyHepatitis BPathologyHepatitis B VirusStem Cell Biology	2011	114
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma J. Liu, Zhaorui Lian, Shuai Han, Oncogene Tumor BiologyHepatologyViral HepatitisLiver PhysiologyHepatobiliary Tumor	2005	111
HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis Wenliang Wang, Thomas London, Laura Lega, Hepatology	1991	110

Page 1